Seminars in Oncology
Volume 33, Supplement 3 , Pages 3-6, February 2006

Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)

  • Sean Whittaker

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint requests to Sean Whittaker, MD, FRCP, St Johns Institute of Dermatology (St Thomas’ Campus), Guys and St Thomas’ Hospital, London, SE1 7EH United Kingdom

St Johns Institute of Dermatology, Guys and St Thomas’ Hospital, London, UK

Mycosis fungoides and Sezary syndrome, collectively known as cutaneous T-cell lymphomas (CTCLs), are low-grade, indolent, clonal, non-Hodgkin’s lymphomas consisting of CD4+ CD45RO+ T cells with a CLA+ CCR4+ skin-homing phenotype. There are several variants of primary CTCLs with differences in clinical behavior and prognosis. Currently, the precise etiologies of mycosis fungoides and Sezary syndrome are unknown. This article reviews our current understanding of the pathogenetic abnormalities involving genomic mutations, abnormal cDNA expression, and dysregulation of signaling pathways in CTCL.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This supplement was supported by an unrestricted educational grant from Zeneus Pharma Ltd.

 Dr Whittaker has served as a consultant to Zeneus, Genmab, and Ligand.

PII: S0093-7754(05)00509-9

doi:10.1053/j.seminoncol.2005.12.015

Seminars in Oncology
Volume 33, Supplement 3 , Pages 3-6, February 2006